Cargando…
Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience
BACKGROUND: Accurate diagnostic biomarker testing is crucial to treatment decisions in breast cancer. Biomarker testing is performed on core needle biopsies (CNB) and is often repeated in the surgical specimen (SS) after resection. As differences between CNB and SS testing may alter treatment decisi...
Autores principales: | Slostad, Jessica A., Yun, Nicole K., Schad, Aimee E., Warrior, Surbhi, Fogg, Louis F., Rao, Ruta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761085/ https://www.ncbi.nlm.nih.gov/pubmed/35733293 http://dx.doi.org/10.1002/cam4.4843 |
Ejemplares similares
-
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens
por: Tsuda, Hitoshi, et al.
Publicado: (2010) -
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
por: Qi, Peng, et al.
Publicado: (2021) -
Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer
por: Jeong, Ye Sul, et al.
Publicado: (2020) -
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
por: Saghir, Hani, et al.
Publicado: (2022) -
Ductal carcinoma in situ in core needle biopsies and its association with extensive in situ component in the surgical specimen
por: Barbalaco Neto, Guerino, et al.
Publicado: (2012)